Phase II Study of a Non-platinum-containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab (PPB) as Initial Therapy for Patients with Advanced Lung Adenocarcinomas

HYPOTHESIS: Many patients with lung cancers cannot receive platinum-containing regimens due to co-morbid medical conditions. We designed the PPB regimen of paclitaxel, pemetrexed, and bevacizumab to maintain or improve outcomes while averting the unique toxicities of platinum-based chemotherapies. M...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Thorac Oncol
Autors principals: Pietanza, Catherine M., Hellmann, Matthew D., Fiore, John J., Smith-Marrone, Stephanie, Basch, Ethan M., Schwartz, Lawrence H., Ginsberg, Michelle S., Shouery, Marwan, Newman, Samantha K., Shaw, Mary, Rogak, Lauren J., Lash, Alex, Hilden, Patrick, Kris, Mark G.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4877255/
https://ncbi.nlm.nih.gov/pubmed/26964771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2016.02.018
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars